Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of cancer"
DOI: 10.1038/s41416-021-01557-w
Abstract: BACKGROUND Hypertension and proteinuria are common bevacizumab-induced toxicities. No validated biomarkers are available for identifying patients at risk of these toxicities. METHODS A genome-wide association study (GWAS) meta-analysis was performed in 1039 bevacizumab-treated patients of… read more here.
Keywords: genome wide; study; hypertension proteinuria; hypertension ... See more keywords
Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218774895
Abstract: Bevacizumab (Avastin) is a recombinant humanized monoclonal antibody used for the management of various solid malignancies including colorectal, lung, brain, renal, and ovarian cancers as well as age-related macular degeneration of the eye. It is… read more here.
Keywords: atypical hemolytic; uremic syndrome; hemolytic uremic; bevacizumab induced ... See more keywords
Bevacizumab-induced Aortic Arterial Thrombosis
Sign Up to like & getrecommendations! Published in 2018 at "Internal Medicine"
DOI: 10.2169/internalmedicine.0209-17
Abstract: A 65-year-old man was diagnosed with advanced non-small, non-squamous lung cancer. He was treated with chemotherapy containing bevacizumab as well as cisplatin and pemetrexed. After 2 courses of treatment, computed tomography revealed that his abdominal… read more here.
Keywords: bevacizumab; treatment; induced aortic; aortic arterial ... See more keywords